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ABSTRACT 
 
Down syndrome is the commonest cause of congenital developmental disability in 
industrialized countries, where it occurs in approximately 1.4 per 1000 live births.  In South 
Africa, the birth prevalence of Down syndrome was documented as 1.8 and 2.09 per 1000 live 
births in urban and rural populations, respectively. The physical, psychosocial and emotional 
burden of Down syndrome on affected families is significant. 
 
The aim of this study was to determine the reproductive choices of women with a child with 
Down syndrome, aged 1 year or older.  The survey was conducted using a structured 
questionnaire.  The sample consisted of fifty women; 36 African, 4 Asian and 10 Caucasian. 
The questionnaire assessed the mothers’ knowledge of Down syndrome prior to diagnosis, 
what counselling was received and how this knowledge was utilised.  Information was also 
obtained on the mothers’ use of family planning, the knowledge and use of prenatal medical 
genetic screening and diagnosis, and what decisions would be made in future pregnancies. 
 
None of the sample group of mothers had prenatal diagnosis in their pregnancy with their 
Down syndrome child, but 76% (38) said that they would want prenatal diagnosis in any 
future pregnancies.  Of the 50 mothers, 21 (42%) said they would terminate a pregnancy if 
Down syndrome had been detected, 26 (52%) said they would not, and 3 (6%) said they were 
unsure what they would have done if faced with this decision.  Of the Caucasian women, 40% 
(4) said they would opt for termination of pregnancy, 40% (4) said they would not and 20% 
(2) were unsure. Of the African and Asian women, 52.8% (19) and 75% (3) respectively said 
they would not terminate an affected fetus. 
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The information from this study can be used to improve the understanding of how women and 
their families cope with their children with Down syndrome and give insight for the provision 
of more effective and comprehensive genetic counselling.  
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NOMENCLATURE 
 
• AMA = Advanced maternal age: Pregnant women over the age of 35 years 
• Amniocentesis = Procedure to obtain a sample of amniotic fluid from the uterus  
• Anaphase = The stage of cell division when the chromosomes leave the equatorial 
plate and move to opposite poles of the spindle  
• Anaphase Lag = The loss of a chromosome as it migrates to the pole of the cell during 
anaphase leading to monosomy in the resulting cell  
• Chromosomes = the structures within each cell nucleus containing the genetic 
information (DNA). They are transmitted from one generation to the next via gametes 
• Cordocentesis = Procedure of obtaining fetal blood samples for prenatal diagnosis 
• CVS = Chorionic villus sampling: Procedure to obtain chorionic villi from the 
chorionic membrane of the fetus 
• Homolog = one of the chromosomes in a pair of chromosomes that contain identical 
loci in meiosis  
• Meiosis = Cell division which occurs in the gamete formation with halving of the 
somatic number of chromosomes resulting in haploid (one set of chromosomes i.e. 23) 
gametes  
• NT = Nuchal Translucency: Prenatal test involving measuring of the thickness of a 
fluid filled space behind the neck of the fetus 
• PD = Prenatal diagnosis: Diagnostic testing during pregnancy (e.g. amniocentesis, 
CVS or cordocentesis) to confirm whether or not a fetus is affected with a particular 
disorder 
• PCR = Polymerase chain reaction: Amplification of a particular piece of DNA 
 xiv 
• TOP = Selective termination of pregnancy 
• Translocation = The transfer of genetic material from one chromosome to another 
• Triple Test = A screening test done during the second trimester of pregnancy which 
gives a risk for having a fetus with Down’s syndrome by measuring and computational 
analyzing of the levels of serum α-fetoprotein, oestriol and human chorionic 
gonadotrophin  
• Trisomy = The presence of three copies of a chromosome 
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CHAPTER 1 
 
INTRODUCTION 
 
 
During a pregnancy, parents prepare psychologically for the birth of a healthy normal child.  
With the birth of a child with a congenital disorder such as Down syndrome, their loss of 
the anticipated healthy child is immediately experienced.  This creates a crisis for parents, 
the psychosocial effects of which are immense (Hobdell & Deatrick 1996).  Amongst other 
issues that they will have to confront in the future will be whether or not to have more 
children. 
 
Down syndrome was first described in 1866 by Langdon Down. In 1959, Lejeune, Gautier, 
and Turpin (1959) discovered that the cause of Down syndrome was the presence of an 
extra chromosome 21.  Subsequently Down syndrome has become the most highly 
researched and well documented genetic condition.  Over 6000 papers were published on 
Down syndrome before 1980 (Peuschel & Steinberg 1980) with more than 6000 
publications since (Christianson 1996).  Although there are over 12000 publications in the 
world literature on Down syndrome, there are less than 25 papers on Down syndrome in 
African populations (Christianson 1996).   
 
Review of the literature revealed that few papers have dealt with the reproductive 
behaviour of mothers after the birth of a child with Down syndrome. Tips, Smith, Perkins, 
Bergman and Meyer (1963) reported from a study on 24 American women with previously 
high reproductive rates, that there was a sharp decline in their reproductive activity after the 
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birth of a child with Down syndrome.  An average of 49% of mothers had had pregnancies 
prior to the birth of their child with Down syndrome and this rate dropped to 25% 
subsequently. No correlation was seen in the control group.  The reason given by the 
mothers was that their experiences of having a child with Down syndrome were very 
traumatic.  In addition, amongst the aunts of the children with Down syndrome, 47% had 
had pregnancies prior to the birth of this child and this rate dropped subsequently to 9%.   
Ando (1978) found that reproductive activity decreased significantly in Japanese mothers 
who had children with Down syndrome, with the decline of reproduction observed more 
clearly amongst younger mothers.  Elkins, Stovall, Wilroy and Dacus (1986) documented 
that 61 (60.4%) from a sample of 101 American women, who had a child with Down 
syndrome, had no further children. Currently there is only one study on the reproductive 
behaviour of African mothers who have had children with Down syndrome (Mgone 1982), 
and it showed that reproductive behaviour in those mothers remained unchanged after the 
birth of a child with Down syndrome. 
 
1.1 DOWN SYNDROME 
Chromosome abnormalities account for about 50% of all spontaneous miscarriages and 
0.5-1% of live born babies (Mueller & Young 2005).  Down syndrome is the most common 
autosomal chromosomal syndrome in live born infants and is the commonest cause of 
congenital developmental disability in industrialized countries (Baird & Sadovnick 1989).   
 3 
1.1.1 Causes of Down syndrome 
Down syndrome is due to the presence of extra chromosome 21 material, which can be 
acquired by non-disjunction (trisomy), translocation or mosaicism.  
 
1.1.1.1 Non-disjunction Down syndrome 
Most Down syndrome, found in 94% of affected individuals, results from a free trisomy of 
chromosome 21 due to a non-disjunction event during meiosis (Jones 1997).  Because of 
the increasing risk of meiotic error as a woman gets older, the occurrence of non-
disjunction Down syndrome increases as the maternal age increases (Harper 2004).  The 
birth prevalence of Down syndrome in infants of women under 25 years of age is 
considered to be low, less than 1 in 1000, although it rises slightly in very young mothers.  
The risk rises above the overall population risk at a maternal age of 30 years. At a maternal 
age of 40 years, the risk is approximately 1% and rises significantly thereafter (Harper 
2004).  Figure 1.1 shows the risk of Down syndrome increases in a gradual, linear fashion 
until about age 30 and increases exponentially thereafter.  
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FIGURE 1.1: Estimated risk of Down syndrome according to maternal age (Newberger 
2000) 
 
Recurrence risks for non-disjunction Down syndrome are increased over the normal risk, 
but the increase does not show a simple relationship to maternal age (Harper 2004). 
Recurrence for Down syndrome is about 1% for women under 35 years of age.  The 
recurrence risk for a mother over the age of 37 is calculated as the age related risk + 1% 
(Harper 2004).  
 
1.1.1.2 Translocation Down syndrome 
Another cause of Down syndrome is chromosomal translocation, which occurs in about 
3.3% of individuals with Down syndrome (Jones 1997).  The rearrangement of 
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chromosomes in translocation Down syndrome usually involves the acrocentric 
chromosome 14, less commonly chromosomes 22, 13, or 15 and rarely the other 
chromosome 21 (Jones 1997) with chromosome 21, therefore representing an unbalanced 
translocation. 
 
The genetic risks of recurrence depend on the type of translocation and whether one of the 
parents carries a balanced translocation i.e. an accurate amount of genetic material.  If there 
is a balanced translocation in the parental chromosomes, the recurrence risk can be up to 
10%, unless the rare 21/21 translocation occurs where recurrence risks are 100% (Harper 
2004).   
 
1.1.1.3 Mosaic Down syndrome 
Mosaicism occurs in about 2.4% of individuals with Down syndrome (Jones 1997). In 
mosaicism, two cell lines are present, some of which have 46 chromosomes and the other 
having 47 chromosomes due to the presence of an additional chromosome 21.  Mosaicism 
usually results from a mal-segregation of homologs, or an anaphase lag of one homolog, 
which occurs postzygotically; the cell mixture arises after fertilization, usually when some 
of the cells in the developing fetus lose one of the chromosome number 21’s at anaphase 
lag. Alternatively, a normal gamete arises and due to non-disjunction as cell division 
occurs, a cell line arises with the presence of an extra chromosome 21 (Mckinlay Gardner 
& Sutherland 2004).  The recurrence risk for mosaic Down syndrome is approximately 1% 
(Jones 1997). 
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1.1.2 Birth Prevalence of Down syndrome 
Down syndrome is the most common genetic pattern of malformation in man, occurring in 
1 in 660 newborns in industrialised countries (Jones 1997). The rate of trisomies is 
however subject to marked variation due to maternal age and the birth prevalence will thus 
vary according to the maternal age structure of the population (Brock, Rodeck & Ferguson-
Smith 1992) as reflected in developing countries such as South Africa.  The birth 
prevalence also varies according to the availability of medical genetic antenatal screening, 
prenatal diagnosis and the option of termination of pregnancy.  In industrialised countries, 
about 50% of fetuses with Down syndrome are detected prenatally.  With the impact of 
antenatal screening and prenatal diagnosis, the birth prevalence of Down syndrome is 
adjusted to approximately 1.43 to 1.54 per 1000 live births (Mueller & Young 2001).  Birth 
prevalence has been documented as 2.3 per 1000 in middle and low-income countries but 
as low as 1.2 per 1000 in high-income countries (Christianson, Howson & Modell 2006). 
 
Modell, Kuliev & Wagner (1992) documented that in Western Europe in the 1950’s, the 
birth prevalence of Down syndrome was approximately 2.5 per 1000 live births, of which 
the majority were born to mothers over the age of 35 years.  By 1980, the proportion of 
older mothers decreased to between 5% and 9% due to the use of family planning, with the 
birth prevalence of Down syndrome decreasing to as low as 1.2 per 1000 live births, of 
which the majority were born to younger mothers. Since the mid-1980’s the proportion of 
older mothers in Europe has been on the increase because of women delaying reproduction 
until later in life.  However, the minority of infants born with Down syndrome are born to 
older mothers (Christianson & Modell 2004; Christianson et al 2006), because of the 
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availability and use of services for antenatal screening and for prenatal diagnosis, and the 
option of termination of pregnancy (Christianson et al 2006).   
 
The situation is remarkably different in developing countries such as South Africa, where 
the birth prevalence of Down syndrome is higher due to a high percentage of women being 
of advanced maternal age (United Nations Fund for Population Activities 1998) and the 
availability of antenatal screening and prenatal diagnosis services and the option of 
termination of pregnancy being either not available to a large proportion of the population 
or not accessed by those who have it available (Schön 2004). 
 
The percentages of births to women over 35 years of age range from 11-18% in developing 
countries and 5-9% in industrialized countries (Christianson et al 2006; United Nations 
Fund for Population Activities 1998).   In industrialized countries, the minority of infants 
with Down syndrome were born to mothers over the age of 35 years (advanced maternal 
age), whereas in South Africa, studies of black neonates with Down syndrome have shown 
that 55% of infants with Down syndrome were born to mothers of advanced maternal age 
(Kromberg et al 1992).   
 
It was not until 1955 that the first black African children with Down syndrome were 
described (Luder & Musoke 1955).  The previously held belief that Down syndrome was 
rare amongst black Africans was shown to be incorrect when Adeyokunno (1982) reported 
in a retrospective study a birth prevalence of 1.16 per 1000 live births at an academic 
hospital in Nigeria.  In South Africa, Kromberg, Christianson, Duthie-Nurse, Zwane and & 
 8 
Jenkins (1992) reported a birth prevalence of 1.68 per 1000 live births at the Chris Hani 
Baragwanath Hospital, refined to 1.8 per 1000 live births for infants born in urban 
Johannesburg, Gauteng (Christianson 1996).  Delport et al (1995) documented a birth 
prevalence of 1.33 per 1000 live births in a Pretoria academic hospital.  The birth 
prevalence of Down syndrome in rural South Africa was documented as 2.01 per 1000 live 
births in Limpopo (Venter et al 1995) 
 
1.1.3 Clinical Features of Down syndrome 
An individual with Down syndrome is recognised by a collection of common identifiable 
clinical features which include: hypotonia, a protruding tongue, hyperflexibility of joints 
with short stature, an awkward gait and increased weight as features of the older child and 
adolescence (Jones 1997).  Other features may include microcephaly, brachycephaly, small 
ears, flat nasal bridge, epicanthic folds, short thumbs and fingers, sandal gap, and duodenal 
atresia (Winship 2003; Jones 1997).  About 40% of infants with Down syndrome have 
cardiac anomalies, including endocardial cushion defects, ventricular septal defects, patent 
ductus arteriosus, atrial septal defects, and an aberrant subclavian artery. Hypothyroidism 
may occur in as many as 28% of individuals affected with Down syndrome.  Thyroid 
function should be checked early in life and treated if indicated.  Annual thyroid functions 
tests should be performed thereafter.  In childhood, individuals with Down syndrome may 
have recurrent respiratory infections, intestinal obstruction, hearing loss, eye abnormalities 
and irregular dentition (Jones 1997).   
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The defining clinical features of Down syndrome, which are mostly similar in different 
ethnic groups, and their frequency, are shown in Table 1.1 (Jones 1997).   
 
TABLE 1.1: Principle features in neonates with Down syndrome 
Organ System Clinical Feature Frequency (%) 
Flat facial profile 
 
90 
Excess skin on back of neck 
 
80 
Craniofacial features 
Slanted palpebral fissures 
 
80 
Hypotonia 80 
Poor Moro reflex 85 
Central Nervous System 
Hyperflexibility of large joints 
 
80 
Dysplasia of pelvis on 
radiographs 
 
70 
Anomalous auricles 60 
Dysplasia of midphalanx of 
fifth finger 
60 
Clinodactyly 
 
50 
Musculoskeletal System 
Single palmar crease 
 
45 
 
The diagnosis of Down syndrome can be made soon after birth with the most common 
presenting feature being hypotonia.  The newborn period is also characterized by lethargy 
and excess nuchal skin (Mueller & Young 2001).   Christianson, Kromberg and Viljoen 
(1995) reported that some of the craniofacial features in black neonates with Down 
syndrome overlap significantly with the features found in normal black neonates.  This 
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made the diagnosis more difficult, especially for health care workers with limited 
experience of Down syndrome.  They also stated that there was a lack of awareness by 
mothers of infants with Down syndrome who did not recognize the differences between 
their infant with Down syndrome and normal newborns.  Christianson and Kromberg 
(1996) found that 83% of mothers with African infants with Down syndrome did not 
recognise any facial differences in their affected child compared to other normal infants.  
They observed that awareness of these mothers was often delayed until delayed milestones 
in their infant with Down syndrome were noticed and subsequently this led them to bring 
the problem to the attention of medical personnel. 
 
 Individuals with Down syndrome all have intellectual disability and delayed milestones. 
The rate of developmental progress slows with age (Jones 1997). Intellectual disability (ID) 
is defined as limitations in intellectual functioning, which includes difficulties in learning 
and performing daily life skills. Intellectual disability can be classified as mild, moderate, 
severe or profound, based upon IQ (intelligence quotient) ranges. A person with a “severe” 
or “profound” disability may be unable to learn basic social skills such as speech, basic 
motor skills including walking and personal care, and is likely to require supported 
accommodation (WHO 1992). 
 
Intellectual disability places a great burden on individuals, their families, society and the 
health care system, as it is serious and lifelong (Christianson, Zwane, Manga, Rosen, 
Venter, Downs & Kromberg 2002).  Limited information is available on the prevalence of 
intellectual disability and on associated epidemiological factors in developing countries. 
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Christianson et al (2002) performed a study on intellectual disability in rural South Africa 
and defined severe intellectual disability (ID) when general intelligence quotient (GIQ) was 
less than 55 and mild ID when GIQ was 56-80.  Jones (1997) reports that the IQ range for 
children with Down syndrome is generally 25 to 50. The IQ in individuals with Down 
syndrome decreases as the child gets older (Jones 1997; Gath 1994).  The mean IQ for 
older individuals is 24 although there have been reports on individuals with that over 50 
(Jones 1997). 
 
Behavioural problems are common in Down syndrome and are a common and perturbing 
complication of intellectual disability (Gath 1994).  Epidemiological studies show that 
behavioural disorders become more common with decreasing levels of intellectual 
functioning (Gath & Gumley 1986).  Gath (1994) reported that half the children with Down 
syndrome at the age of 8 years had significantly more behaviour problems than unaffected 
children of the same age.  She noted that 25% of the children with Down syndrome had 
attention deficit disorder.  Individuals may be mischievous and obstinate and 13% have 
serious emotional problems (Jones 1997). 
 
Down syndrome adults are at high risk of developing Alzheimer’s disease, becoming 
apparent usually in the fifth decade but earlier in some cases.  This is much earlier than the 
general population (Dalton & Wisniewski 1990).   Distress, confusion and other signs of 
premature ageing accompany the loss of skills (Gath 1994).  Approximately 30 -60% of 
adults acquire cataracts (Jones 1997). 
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1.1.4 Prognosis of Individuals with Down Syndrome  
The prognosis of infants born with a severe congenital disorder depends on the level of 
development and availability of health services. In high-resource settings, up to 70% of all 
birth defects can be avoided, infant lives saved or disability considerably improved 
(Christianson & Modell 2004) by comparison to low-income settings where a majority of 
affected infants die undiagnosed or are disabled (WHO 1985; Christianson, Howson & 
Modell 2006).  More than 30% of infants with a serious congenital disorder in middle-
income countries, and at least 50 % in low-resource countries die within infancy or 
childhood (Christianson & Modell 2004). The population prevalence of Down syndrome in 
high resource countries is close to 70% of its birth prevalence (Christianson & Modell 
2004).  In industrialized settings, the life expectancy of individuals with Down syndrome 
has improved in recent years compared to what it was decades ago (see figure 1.2) as 
complications are treated and educational and social support is available (Christianson & 
Modell 2004).  
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FIGURE 1.2: Median age at death of people with Down syndrome by race – United States 
1968-1997 (CDC data 1968-1997) 
 
A cohort study in France (1984-1990) of 280 Down syndrome fetuses, recorded that 43% 
(120) had died by the end of the first year of life.  Termination of pregnancy had been 
carried out in 76 (27%) of the pregnancies.  The remaining mortality was due to late 
spontaneous abortion or stillbirth (11 or 4%), or death during the first year of life (33 or 
12%).  Of the 192 live born infants with Down syndrome, 17% (33) died during the first 
year of life, with half of these in the neonatal period (Julian-Reynier et al 1995). Baird & 
Sadovnick in 1989 showed that life expectancy in children with Down syndrome is 
significantly poorer if congenital heart disease is present. They had also documented (1987) 
that for patients with congenital heart disease (CHD), 76.3% survive to 1 year of age; 
61.8% to age 5; 57.1% to age 10; 53.1% to age 20 and 49.9% to age 30.  For patients 
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without CHD, survival to the same ages is 90.7%; 87.2%; 84.9%; 81.9% and 70.2%, 
respectively.  Mortality from respiratory disease, predominantly pneumonia, and also other 
infectious diseases is much higher than in the general population (Jones 1997). 
 
In lower resource nations, the mortality in infancy and early childhood of children with 
Down syndrome is far greater (Christianson & Modell 2004).  In South America 26.4% of 
infants with Down syndrome die before their first birthday (Castilla, Rittler, Dutra, Lopez-
Camelo, Campana 1998).  Christianson et al (2002) documented that two out of three 
children with Down syndrome in South Africa die prior to 2 years of age.   
 
For those children who survive, there is lifelong chronic disability with needs that exceed 
those of most other children (Gath 1990). These needs include early developmental 
enrichment programs, including physiotherapy and speech therapy which are recommended 
(Jones 1997; Cohen, Nadel, Madnick 2002), special education needs, and medical needs 
due to recurrent respiratory infections, and other complications such as those listed above 
(Jones 1997).   
 
It was estimated that the cost of medical care in the public service in South Africa for one 
individual with Down syndrome was on average R20 000 per year in 2001, excluding the 
care of cardiac abnormalities, which would cost in the region of R50 000 if surgery were 
required (Policy Guidelines for the management and prevention of Genetic Disorders Birth 
Defects and Disabilities 2001).  Given that 2300 infants with Down syndrome will enter the 
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health care system in South Africa per year, the estimated cost of caring for each annual 
cohort of these children is approximately R100 million (Christianson et al 2006). 
 
1.1.5 Care of People with Down syndrome 
The burden of congenital disorders worldwide has been greatly underestimated.  It has not 
been recognised, especially in middle and low-income nations, that there is a great need, 
and that possibilities exist for care and prevention of congenital disorders. However, 
prognosis improves as care improves; an increasing proportion of infants with congenital 
disabilities survive as services become available.  As the number of infants that survive 
increases, the number requiring care increases incrementally (Christianson & Modell 
2004). 
 
Care for individuals with congenital disorders includes diagnosis, therapeutic intervention 
and genetic counselling with psychosocial support (WHO 1999; Christianson & Modell 
2004; Christianson et al 2006). 
Care for individuals with Down syndrome therefore involves: 
1) Early postnatal diagnosis 
2) Treatment 
i) Medical treatment for congenital heart defects, recurrent infections,        
hypothyroidism and other medical complications 
ii) Surgical treatment for congenital heart defects, duodenal atresia and other 
malformations 
 iii) Neurodevelopmental therapy 
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3) Genetic Counselling 
 
1.1.5.1 Diagnosis 
A clinical and family history, a physical examination and laboratory testing are required to 
make a medical genetic diagnosis.  A realistic care plan, taking the family, community 
circumstances and available health care facilities into account, can then be considered once 
an accurate and hopefully early diagnosis has been confirmed (Christianson & Modell 
2004).  This is as important for Down syndrome as any other birth defect, especially in the 
situation in South Africa where the clinical diagnosis of Down syndrome is poor 
(Christianson & Kromberg 1996). 
 
1.1.5.2 Treatment 
Medical care requires an organised approach of assessment, monitoring, and vigilance. 
Once an early and correct diagnosis is made in the individual, the associated problems can 
be recognised. Treatment for an individual who has been diagnosed with Down syndrome 
includes cardiac evaluation with treatment if necessary, prompt treatment of infection, 
regular dental care, monitoring of thyroid function and treatment of hypothyroidism when 
indicated and prevention of obesity (Roizen & Patterson 2003). The best option for 
neurodevelopmental therapy to help an affected individual in middle and low-income 
settings is community based rehabilitation run by primary health care practitioners with 
local people trained to assist (Christianson & Modell 2004).  
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Many simple and therapeutic measures for people with Down syndrome exist that can be 
given in the primary health care setting.  The more complex interventions such as cardiac 
assessment and surgery for children with Down syndrome may be available in secondary 
and tertiary hospitals.  However complex procedures such as cardiac surgery may not be 
offered to such a child, because of lack of facilities and competing priorities (Christianson 
& Modell 2004).  
 
Improvements in the quality of life of individuals with Down syndrome have resulted from 
advances in medical care, early educational intervention with support in educational 
settings, and the identification and treatment of psychiatric disorders found in Down 
syndrome such as depression, disruptive behaviour disorders, and autism (Roizen & 
Patterson 2003). 
 
1.1.5.3 Genetic Counselling 
Genetic counselling is an educational process by which individuals or relatives, at risk of a 
congenital disorder, are informed of the nature of the genetic disorder, the probability of 
developing or transmitting it and the options available to them in which it can “be 
prevented, avoided or ameliorated” (Harper 2004 p.3). Genetic counselling plays an 
important role in the co-ordination of the multi-disciplinary and long-term management of 
patients as the necessary referrals are made and genetic counsellors are aware of what 
services are available to patients.  Genetic counselling also aims to provide psychosocial 
support. Starke & Moller (2002) reported that by seeking information and gaining 
knowledge about the diagnosis, parents can handle their reactions of having a child with a 
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chronic illness.  It is thought that this is a way for parents to restore order in a “chaotic 
existence”.  Genetic counsellors are trained to meet these needs in parents of children with 
a congenital disorder. 
 
Genetic counselling for Down syndrome occurs in two different settings: prenatal and 
postnatal.  In prenatal counselling for Down syndrome, the risk of having a baby with 
Down syndrome would be discussed, depending on the family history, the mother’s age 
and results of medical genetic screening (see section 1.1.6.2).  Prenatal diagnostic 
situations can be complex and always carry some degree of prognostic uncertainty, making 
decisions and preparation for the future difficult (Fonda Allen & Mulhauser 1995).  The 
options available after prenatal diagnosis of a congenital disorder are often limited, and the 
resulting psychosocial and emotional consequences are far-reaching, making the 
experience for parents a significant burden. Previous dreams and hopes for a healthy baby 
are threatened, and their ability to cope and their views of life may be challenged.  An 
abnormal fetus may greatly affect their bonding with the infant, their belief in a good 
world, interactions with each other, as well as their perception of future risks (Fonda Allen 
& Mulhauser 1995). The genetic counselling process aims to empower individuals and 
their families experiencing such turmoil through informing them and providing 
psychosocial support, thus enabling them to make suitable decisions. 
 
In post-natal counselling where a baby is suspected of having Down syndrome, an 
examination and chromosome analysis is performed, or parents are counselled on a 
confirmed result for Down syndrome.  The clarification of the diagnosis, the cause, clinical 
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features, prognosis, treatment options and risks for future pregnancies are discussed with 
parents and the necessary referrals are made.  A congenital disability has lifelong 
implications for the individual and family and genetic counselling provides a support 
service. 
 
Genetic counselling is non-directive and focuses on the accurate and clear presentation of 
facts, risks and options, and one of the most important goals of genetic counselling is to 
help patients understand the reproductive options available to them (D’Alton & DeCherney 
1993). 
 
1.1.6 Reproductive Options of Women at Risk 
The prevention of congenital disorders based on reproductive options includes family 
planning, public education about prenatal risks, and prenatal screening and diagnosis for 
fetal anomalies (Penchaszadeh 2002; Christianson et al 2006).  Using these options, 
women at risk thus have the reproductive choice to prevent occurrence or recurrence of a 
child with Down syndrome (Christianson & Modell 2004). 
 
1.1.6.1 Family Planning 
Family planning allows couples to have the option of when to start and complete their 
family, to determine their family size, and to plan spacing between children.  It is a 
woman’s basic right, and plays a positive role in reproductive health and in the 
improvement of pregnancy outcomes (United Nations Fund for Population Activities 
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1998).  When women in a population choose to complete their families at a younger age, it 
is associated with the reduction of chromosomal trisomies, particularly Down syndrome 
(Christianson & Modell 2004). 
 
Penchaszadeh (2002) summarised that in developing countries, rates of Down syndrome 
that are maternal age-specific are similar to those in developed countries but that there is 
data suggesting that the overall birth prevalence of chromosome disorders is higher in 
developing countries.  This could either be as a result of the lack of family planning 
services or lack of access to them resulting in a higher proportion of births to women of 
advanced maternal age.  As discussed previously (in section 1.1.2), births to women over 
35 years of age are more common in developing nations than in industrialized countries 
(United Nations Fund for Population Activities 1998).  The WHO (2000) estimated that in 
developing countries with high fertility, the reduction to 2 to 3 children per family together 
with encouragement to complete reproduction before the age of 35, family planning can 
reduce the birth prevalence of Down syndrome by 50%. 
 
1.1.6.2 Medical Genetic Screening for Down syndrome 
Medical screening is a public health activity that aims at the prevention of disease on a 
population basis, where screening is offered to all people in a defined population.  Down 
syndrome screening programmes aim to identify mothers at risk of having a child with 
Down syndrome so that they may receive genetic counselling regarding their specific 
circumstance and the options available (Christianson & Modell 2004). 
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Medical genetic screening for Down syndrome during pregnancy is undertaken by 
determination of advanced maternal age, biochemical screening in the first and second 
trimesters, and ultrasound scanning.  Women identified at being at an increased risk for 
having a fetus with Down syndrome should then have the choice of having the diagnosis 
confirmed by prenatal testing.  Once confirmed, women through genetic counselling can be 
offered the choice of TOP or continuing with the pregnancy. 
 
1.1.6.2.1 Advanced Maternal Age 
As discussed in section 1.1.2, the rate of trisomy 21 increases with maternal age.  A woman 
should be referred for genetic counselling when she is of advanced maternal age (AMA), 
which is from the age of 35 years and older.  At the age of 35, a woman has a risk of 1 in 
386 of having a baby with Down syndrome, and this risk increases with advancing 
maternal age (Hook et al 1983).   
 
1.1.6.2.2 First Trimester Screening 
First trimester screening differs substantially in the public and private (fee for service) 
health sectors in South Africa.  In the private sector, first trimester biochemical screening 
for Down syndrome has been established using pregnancy-associated plasma protein-A 
(PAPP-A) and the free beta subunit of human chorionic gonadotropin (Fß-hCG) levels 
present in maternal blood.  Reduced levels of PAPP-A and increased levels of ß-hCG are 
found in the first trimester of pregnancies with fetuses affected by Down syndrome 
(Wheeler & Sinosich 1998).  One fetal ultrasound marker, nuchal translucency (NT), has 
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been shown to be effective for first trimester screening for Down syndrome.  NT screening 
can be offered to women to a limited extent in the private and public sector, if they book 
for antenatal care in their first trimester of pregnancy. However, it is a procedure that 
requires appropriately trained operators, of which there are few in South Africa.  NT 
screening is performed between 11 and 14 weeks gestation and involves measuring the 
thickness of a fluid filled space behind the neck of the fetus.  The NT thickness changes 
with gestational age and measurement of the NT provides a modified risk, relative to the 
age-related risk, for having a fetus with a chromosome abnormality/Down syndrome.  
Increased nuchal translucency is also associated with congenital heart disease, severe 
skeletal dysplasias and other fetal abnormalities.  Approximately 5% of normal fetuses 
would also have an increased NT measurement (Nicolaides, Sebire & Snijders 1999). 
Prospective studies have shown that screening by a combination of NT and Fß-hCG and 
PAPP-A can identify 90% of fetuses with trisomy 21 and other major chromosomal 
abnormalities, with a false-positive rate of 5% (Nicolaides 2005). 
 
1.1.6.2.3 Second Trimester Screening 
The maternal serum triple test (MSTS) which measures AFP, human chorionic 
gonadotrophin (hCG), and oestriol is used to screen for Down syndrome in pregnant 
women in the second trimester of pregnancy (Chard & Macintosh 1995).  It identifies 
approximately 60% of cases of Down’s syndrome, with a false positive rate of 6.6%.  If 
ultrasonography is used to verify gestational age, the false positive rate is reduced to 3.8%. 
It is essential that this test be done between 16 and 18 weeks gestation (Haddow, Palomaki, 
Knight et al 1992).  Other factors, such as maternal weight, maternal diabetes, ethnicity, 
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twin pregnancy and the previous maternal history can influence the results of the MSTS 
(Wald, Cuckle, Densem et al 1988), and women should be made aware of the limitations. 
 
Fetal anomaly scanning is used in the second trimester, between 18 and 20 weeks gestation.  
It is important that it is performed by skilled operators using high quality equipment. It is 
also important that referring doctors understand the possible anomalies that may be seen 
and how to explain these findings to the patient.  Ultrasound in the second trimester 
diagnoses 50-70% of cases of Down syndrome by detecting soft markers (Shipp & 
Benacerraf 2002). 
 
Screening for Down syndrome in pregnant women ultimately increases or decreases their 
risks for having a baby with Down syndrome and thus influences a woman’s decision as to 
whether or not she should have prenatal invasive testing. 
 
1.1.6.3 Prenatal Diagnostic Testing 
Prenatal diagnosis is the identification of disease or condition in a fetus or embryo prior to 
delivery.  Ultrasound and amniocentesis were first used for prenatal diagnosis of fetal 
abnormalities due to neural tube defects and chromosomal abnormalities in the 1970’s 
(Fonda Allen & Mulhauser 1995).  Amniocentesis is the most common invasive procedure 
used to obtain fetal cells for prenatal diagnosis of chromosomal abnormalities (Brock, 
Rodeck & Ferguson-Smith 1992).  The procedure is done by direct needling of the 
pregnant uterus with the aid of an ultrasound scan, to obtain a small sample of amniotic 
fluid (≤ 20ml), usually done between 16 and 20 weeks gestation (Harper 2004).  
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Amniocentesis has an associated risk of fetal loss estimated as 0.5 to 1.0% (D’Alton & 
DeCherney 1993).  Cells can also be obtained by chorionic villi sampling (CVS), where 
samples of developing placenta are obtained transcervically or transabdominally at 11-14 
weeks of pregnancy, and by cordocentesis, the extraction of fetal blood from the umbilical 
cord, after 20 weeks gestation (Harper 2004).  The rate of miscarriage proceeding CVS 
exceeds that in amniocentesis by 0.8% (Rhoads, Jackson, Schlesselman et al 1989).  Other 
studies suggest a 2-3% risk of fetal loss and give reports of an excess of limb abnormalities 
possibly related to CVS, especially when done at a gestation earlier than 9 weeks (Harper 
2004).  Cordocentesis was reported to have an associated fetal loss rate of 2.5-5% (Brock, 
Rodeck & Ferguson-Smith 1992). 
 
After amniocentesis or CVS when the pregnancy is still relatively early, cytogenetic 
analysis (karyotyping) on fetal cells is performed, from which major structural and 
numerical chromosomal abnormalities can be detected (Valenti, Schutta & Kehaty 1968).  
Culture failure may occur after amniocentesis in less than 1% of cases and maternal 
contamination is approximately 2% in CVS samples (D’Alton & DeCherney 1993).   
 
Amniocentesis can be performed up to 24 weeks gestation to obtain fetal cells for 
Polymerase Chain Reaction (PCR) and direct DNA analysis without the need to culture the 
cells (Mueller & Young 2001).  This analysis, PCR aneuploidy, can detect the common 
numerical chromosome abnormalities (which include trisomy 21) and has been available at 
the National Health Laboratory Service (Central) in Johannesburg since 2001 (Lane 2005). 
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Harper (2004) reports that most couples that have had a child with Down syndrome do 
elect for prenatal diagnosis in a subsequent pregnancy and that the strength and indication 
for prenatal diagnosis will depend on their perception of the magnitude of the recurrence 
risk and their attitude and own experience.  Before prenatal procedures are contemplated, 
the acceptability of termination of pregnancy to a couple should be considered.  Sometimes 
it is unacceptable to couples based on religious grounds, or because of the attitude of the 
community, or due to a personal ethical view.  Unacceptability of termination however, 
should not rule out the option of prenatal diagnosis as some parents feel it is a way they can 
be better prepared for an abnormal child (Harper 2004).   
 
A person’s previous experience, as well as ethnic and cultural background and religious 
beliefs will affect the acceptability of prenatal diagnosis and the choices to be made if a 
fetal abnormality is diagnosed.  Genetic counselling is essential as parents need to 
understand that the central issue is balancing the risk of an investigative invasive procedure 
against the risk of the birth of an affected child (Harper 2004).   
 
1.1.7 Prenatal diagnosis for Down syndrome in South Africa 
In South Africa, prenatal diagnostic services exist in the private and public sector.  They 
are however only available to the public sector at selected Academic and State hospitals.  
The resources are limited as many of the techniques require high quality, expensive 
equipment and trained technicians.  
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Some developing countries have followed the example of industrialized nations in 
implementing prenatal screening programs, prenatal diagnosis, the option of amniocentesis, 
and the option of termination of pregnancy if the fetus has Down syndrome.  South Africa 
is a country where improvement of health conditions exposed birth defects, including 
Down syndrome, as a major cause of infant mortality (Penchaszadeh 2002).  Genetic 
services for genetic counselling and prenatal diagnosis have been available in Johannesburg 
since 1979, but have been underutilised by the African population (Kromberg et al 1989). 
However, a large proportion of the population remain unaware of this genetic service 
(Schön 2004).  The mean gestational age that many women present at a tertiary care centre 
such as Baragwanath Hospital is 28 weeks (Kromberg et al 1992), which is too far 
advanced to offer invasive prenatal testing.   
 
Although it is thought that women who receive prenatal care have fewer complications in 
pregnancy and during delivery, it has been found that there is a difference in the utilisation 
rate of services that offer prenatal diagnosis by people of different ethnic origin (Sokal et al 
1980; Brett et al 1994; Kupperman et al 1996).  Reasons for the difference in utilisation 
have been suggested; Epstein et al (1972) and Shino & Kellogg (1977) reported that it was 
due to lack of education; Kupperman et al (1996) proposed that lack of education and 
socio-economic factors were the major factors.  Pelser (1998) proposed that the lack of 
awareness and under-utilization of services in South Africa could be due to limited 
knowledge regarding prenatal diagnostic services, as well as the lack of availability of 
prenatal tests.  Pelser (1998) and Schön (2004) reported that medical personnel fail to 
inform women regarding the tests.  Schön (2004) found that women of advanced maternal 
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age present to clinics in time for genetic counselling and prenatal diagnosis but are not 
referred on time by medical and nursing staff.  The researcher feels that this is one of the 
critical issues that needs to be addressed in South Africa. 
 
The prenatal diagnostic techniques described above (section 1.1.6.3) are currently not 
offered routinely in South Africa.  There are few centres with suitably trained doctors to 
offer NT screening, and the accuracy is reduced in MSTS screening due to the lack of 
appropriate equipment and adequately trained professionals to assess correct gestational 
dating. 
 
South Africa has however made tremendous progress over the last decade in the 
development of principles, practice and policy for the initiation and development of a 
national community-based medical genetics programme.  The programme exists for the 
care of people with genetic disorders, birth defects, disability as well as prevention 
(Christianson 2000). 
 
Infant and childhood mortality and morbidity has until recently predominantly been caused 
by infectious diseases and malnutrition in developing nations.  These problems have been 
addressed and mortality is thus declining.  An epidemiological shift is beginning to occur in 
South Africa (Christianson et al 2002).  Genetic disorders and birth defects which 
previously received limited attention from health care planners, have begun to “emerge and 
demand due consideration” (Christianson et al 2002 p.180), as these contribute increasingly 
to infant and childhood mortality.  However, a major threat to this health transition exists in 
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South Africa through the current Human Immunodeficiency Virus (HIV)/ Acquired 
Immune Deficiency syndrome (AIDS) pandemic.  It affects infants, children and adults, 
causing death and disability and is using up an increasing amount of the National 
healthcare budget (Christianson 2000).   
 
HIV/AIDS indirectly creates a quandary in diagnosing fetal chromosomal abnormalities, as 
the invasive procedures used to obtain cells create an increased risk of transmission of the 
virus to the fetus (Tess et al 1998).  Thus after counselling, women can either opt not to 
have prenatal diagnosis for chromosome abnormalities or if they opt for prenatal diagnosis 
be made aware that the fetus is at an increased risk of contracting HIV/AIDS.  
Antiretroviral treatment is not currently available at all the hospitals where the invasive 
procedures are performed and many women decline prenatal testing due to their HIV status 
alone.  An increasing number of women of advanced maternal age who are HIV positive 
are presenting at Genetic counselling clinics (Bee 2005).  Bee (2005) showed that 39% of 
HIV negative women opted to have amniocentesis, whereas only 14% of HIV positive 
women choose this option.  The study concluded that there is no clear understanding of 
mother to child transmission during second trimester amniocentesis, and that there are no 
clear policies in South Africa regarding HIV prophylaxis prior to and after amniocentesis. 
 
Although the local situation has improved over the years, and an essential service is now 
offered to patients, there are many issues that need to be addressed and resolved. 
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1.2 AIMS OF THE STUDY 
The aim of this study was to determine what reproductive decisions are made by South 
African women who live in Johannesburg who have previously had a child with Down 
syndrome.  Attitudes of women who have had children with Down syndrome to having 
further children were explored, as well as to family planning, prenatal screening, prenatal 
diagnosis, their considerations about termination of pregnancy and their emotional 
experience when initially given the diagnosis of their child with Down syndrome.  
Information gained will aim to improve understanding of maternal psychological and social 
factors and responses surrounding the diagnosis of a child with Down syndrome. 
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CHAPTER 2 
STUDY PARTICIPANTS & METHODOLOGY 
 
 
Relevant aspects of Down syndrome including the reproductive options available to women 
were discussed in the previous chapter.  In this chapter the study participants and 
methodology will be discussed.   
 
The research design was a retrospective study, the aim met through the administration of 
face-to-face interviews using a structured questionnaire.  Ethical clearance was obtained 
from the Medical Human Research Ethics Committee (clearance number: M040226).  
 
2.1 RESEARCH TOOL 
The survey was conducted through the use of a structured questionnaire in an interview 
format (Appendix A). An explanation of the study and informed consent was obtained from 
all the women that participated in the study (Appendix B and C). To minimize inter-
personal differences and interviewer bias, the questionnaire was completed by the 
researcher on a face-to-face basis. The researcher ensured that all the questions were 
explained uniformly to all participants and that all questions were fully understood.  A 
translator was used to interpret the questions to mothers, and also the answers from those 
participants who could not speak or understand English. 
 
Deleted: of  face
Deleted: The research design 
was a retrospective, qualitative 
study, the aim met through the 
administration of a structured self-
administered questionnaire.  
Ethical clearance was obtained 
from the Medical Human Research 
Ethics Committee (clearance 
number: M040226). ¶
 31 
The research questionnaire was administered in a structured and standard manner.  The 
following information was gained: 
i) General Information 
a. Social information 
b. Socio-economic status 
ii) Biomedical Information 
a. Previous pregnancy history 
b. Prenatal diagnosis in pregnancy involving child with Down syndrome 
c. Reproductive decisions 
iii) Information on child with Down syndrome 
a. Age of child 
b. Maternal knowledge of Down syndrome prior to birth of child 
iv) Genetic Counselling 
a. Whether mother received counselling 
b. From whom counselling was received 
v) Reproductive decisions made, after birth of child with Down syndrome 
 
2.2 RESEARCH METHOD 
2.2.1 The Population 
The women participants for the research study were South Africans who had a child with 
Down syndrome who had survived to at least 1 year of age.  The sample consisted of 50 
women. 
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2.2.2 The Sampling Method 
Women with children with Down syndrome were accessed from seven sources, listed 
below.  The women were given an explanation of the study and an information sheet 
(Appendix B) and then asked to sign consent (Appendix C) before taking part in the study.   
 
2.2.3 The Sample 
The women were accessed through: 
1) Division of Human Genetics 
The names of mothers of children with Down syndrome were obtained from files of the 
Division of Human Genetics, National Health Laboratory Service (Central) for the years 
1980-2003.  These mothers had attended a Genetic Counselling clinic. 
  
2) Genetic Counselling Clinics 
Mothers of children with Down syndrome who were seen at the Genetic Counselling 
Clinics run weekly at Chris Hani Baragwanath, Johannesburg General and Coronation 
Hospitals were included in the study. These mothers were either coming for genetic 
counselling for the first time or were attending a follow-up appointment. 
 
3) The Memorial Institute (TMI) 
Clinics for children with Down syndrome are run on a monthly basis at the TMI, where 
they attend for ongoing developmental assessment.  These clinics were attended by the 
researcher and mothers were asked if they would participate in the study. 
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4) Down syndrome South Africa (DSSA) 
The mothers of children with Down syndrome who attended weekly DSSA support group 
meetings at TMI were approached to take part in the study. The Down syndrome support 
group in Lenasia was attended by the researcher and mothers of children with Down 
syndrome were approached.  The researcher also interviewed the mothers on the DSSA 
committee who have children with Down syndrome. 
 
5) Word of Mouth 
Families known to colleagues were introduced to the interviewer and home visits arranged 
to conduct the interviews.  
 
6) Cardiac Clinic 
Contact was made with a paediatric cardiologist working at the Johannesburg Hospital.  
Permission was obtained to approach mothers of children with Down syndrome attending 
paediatric cardiology clinic.   
 
7) Speech and Hearing Department 
Interviews were conducted with mothers who attend a Down syndrome support group run 
by the social work department at Chris Hani Baragwanath Hospital. 
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2.3 DATA COLLECTION AND ANALYSIS 
2.3.1 Pilot Study 
A pilot study using the questionnaire (Appendix A) was done on 10 women, prior to 
commencement of the study.  No changes were considered necessary after the pilot study 
and the remaining interviews were conducted with the original questionnaire. 
 
2.3.2 Data Analysis 
The results from the questionnaire were coded and entered onto a spread sheet using 
Microsoft Excel. Chi square testing was performed on the data where comparison was to be 
made between populations.  The following website was used for this purpose: 
http://www.graphpad.com/quickcalcs/contingency1.cfm. 
 
2.4 ETHICAL CONSIDERATIONS 
Ethical clearance was obtained from the Human Research Ethics Committee (Medical) on 
09/02/2004 to undertake this study (Appendix D).  The mothers that were interviewed were 
ensured that confidentiality would be maintained and they were informed that they could 
withdraw from the study at any stage without any detrimental effect in the management or 
treatment of child. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
 
 
The questionnaire (Appendix A) was administered to South African mothers living in 
Johannesburg who have children with Down syndrome in order to determine their 
knowledge regarding Down syndrome, their reproductive choices after having a child with 
Down syndrome and what may have influenced their decisions.  In this chapter, the results 
will be presented in the order elicited from the questionnaire and will be depicted in tables, 
histograms and picture charts.  A discussion is included to further elucidate the particular 
category addressed in the questionnaire.  
 
3.1 DEMOGRAPHICS 
The mothers of children with Down syndrome interviewed in this study were from all 
social classes and various education levels.  They all have a living child with Down 
syndrome who was at least 1 year of age at the time of the study.  Fifty women, 36 African, 
4 Indian and 10 Caucasian (figure 3.1.1), were interviewed.  It was required for this study 
that the child was older than one year of age as these women were considered to have 
experienced some of the emotional and social issues associated with having a child with 
Down syndrome, and also to have had sufficient time to have made choices regarding 
reproduction. 
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FIGURE 3.1.1: Total number of women included in the study 
 
Most of the mothers interviewed, 72% (36), were African women, who used public sector 
medical services.  This was expected as the majority of children with Down syndrome born 
in South Africa are African (Christianson 1996).  The ages of the mothers interviewed 
ranged from 21 years to 56 years.  The mean age was 37.8 years. 
 
The social class of each woman was determined by assessing the woman’s occupation.  In 
the cases where women were currently unemployed, their previous occupation, or the 
occupation of their spouse/partner was taken into account.  Based on international models, 
Schlemmer and Stopforth’s (1979) guide to coding of occupations, was adapted for the 
South African situation.  All occupations were divided into 5 groups, with group 1 being 
the highest social class and group 5 being the lowest: 
Group 1: Professional and Managerial 
Group 2: Middle White-collar 
Group 3: Manual Foreman, Skilled Artisans, Farmers, and Status Equivalent 
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Group 4: Routine Non-Manual and Semi-Skilled Manual 
Group 5: Unskilled Manual and Menial 
 
For this study, the five groups were narrowed down to two classes.  The first, indicating 
higher social status, consists of groups 1-3, and the second, lower social status, consists of 
groups 4 and 5.  The total household income of the woman was determined to ensure 
accuracy of the grouping.  The income was found to be congruent with the occupation for 
each woman with respect to categorization into the social class.  
 
Of the 50 women interviewed, 35 (70%) were from a lower social background and 15 
(30%) were from a higher social class.  Of the African women, 2 (4%) were from a high 
socio-economic background and 34 (68%) were from a low social background, whereas 9 
(18%) of the Caucasian women were from the former and 1 (2%) from the latter (figure 
3.1.2).   
 
For comparison, in South Africa the unemployment rate of women was found to be 
approximately 35% (and 26.2% if men are included) according to the General Household 
survey July 2004 (Statistics South Africa 2005). Of the category of employed people, 
22.4% were in the three most senior occupation categories, which included managers, 
professionals, semi-professionals, and technicians (termed “more skilled”).  Therefore, 
based on occupation, 83.5% of people in South Africa are either unemployed or part of the 
less skilled occupation categories (lower social status) and 16.5% are of higher social class. 
Therefore when comparing the social status of the sample of this study to the statistics of 
the population of South Africa, the Pearson Chi-square value was 6.614 and subsequent p-
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value of 0.01 indicates a significant difference between the two groups and that the sample 
in this study is not an accurate representation of the population of South Africa as a whole. 
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FIGURE 3.1.2: Distribution of socio-economic status among ethnic groups 
 
The mothers were divided into four groups according to their level of education: 
a) Group 1 included women who had no schooling at all 
b) Group 2 included women who had 1 to 7 years schooling 
c) Group 3 included women who had 7 to 12 years schooling 
d) Group 4 included women who had tertiary education 
 
Of the 50 women in the sample, 5 (10%) had no schooling, 11 (22%) had 1 to 7 years 
schooling, 21 (42%) had 7 to 12 years schooling and 13 (26%) had obtained tertiary 
education (figure 3.1.3).   
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FIGURE 3.1.3: Distribution of education level of mothers 
 
For comparison with the South African population, Statistics South Africa (2003) reported 
the level of education of people 20 years and older in the census 2001, and documented that 
17.9% of the population had no education, 22.4% had 1 to 7 years of schooling, 51.2% had 
7 to 12 years of schooling and 8.4% had tertiary education.  The number of women in the 
education groups in this study with reference to their ethnicity, is shown in figure 3.1.4. 
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FIGURE 3.1.4: Distribution of education level among ethnic groups 
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3.2 INFORMATION ON PREVIOUS PREGNANCIES 
The average number of pregnancies that the mothers of children with Down syndrome had 
was 3.4, with a range of 1 to 10 pregnancies and the average number of live born infants 
was 3.0, with a range of 1 to 10.  At the time of the interview, the number of children per 
mother ranged from 1 to 10, with a mean value of 2.9.  The average number of children per 
mother was 2.1 in the Caucasian population, 3.1 in the African population and 3.0 in the 
Asian population.   
 
For comparison, the total fertility rate in South Africa is 2.8.  The total fertility rate 
amongst different ethnic groups in South Africa was recorded to be 3.0 in the African 
population, 1.7 in the Caucasian population and 1.9 in the Asian population (Health 
Systems Trust 2005).   
 
Africans have more children per family on average compared to the Caucasian population, 
thus the birth prevalence of African babies with Down syndrome would be expected to be 
higher.  In addition to having more children (Health Systems Trust 2005), many African 
mothers have their children when they are over the age of 35, increasing their risk for 
having a baby with Down syndrome (Kromberg et al 1992).   
 
3.3 MATERNAL KNOWLEDGE OF DOWN SYNDROME PRIOR TO BIRTH OF CHILD WITH 
DOWN SYNDROME   
The mothers were questioned on their knowledge of Down syndrome prior to their child 
with Down syndrome being born. Of the mothers, 17 (34%) knew about Down syndrome 
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compared to 33 (66%) who did not.  Of the Caucasian women, 90% (9) knew what Down 
syndrome was prior to the birth of their child while only 19% (7) of African women could 
answer in the affirmative (figure 3.3.1). To confirm this knowledge regarding Down 
syndrome, they were asked to give a short description about what they knew about Down 
syndrome.  A mother was regarded as having knowledge of Down syndrome when her 
description included that it was a chromosome abnormality or that affected individuals 
were “slow” or intellectually delayed.   
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FIGURE 3.3.1: Mother’s knowledge of Down syndrome prior to birth of child 
 
Using the Fisher’s exact test to compare the prior knowledge of Down syndrome between 
the African and Caucasian groups, the two-tailed P value of less than 0.0001 was 
statistically significant.  Of the mothers who did know about Down syndrome (17 or 34%) 
however, most (15 of the 17) had only a very basic knowledge and did not fully understand 
the severity or prognosis of the disorder.   
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Pelser (1998) documented in a study done in Pretoria, Gauteng, on women of advanced 
maternal age presenting for genetic counselling that 54.4% of African women and 96.7% of 
the Caucasian women knew about Down syndrome.  However, this study was done at the 
time when there was an extensive education drive in Pretoria to educate the public on 
Down syndrome.  Schön (2004) in a study assessing missed opportunities for AMA genetic 
counselling found that 31% of African women of advanced maternal age presenting at an 
academic clinic knew about Down syndrome.  This figure is comparable to the knowledge 
of Down syndrome in mothers in this study. 
 
Christianson et al (1995) proposed possible reasons for the difference in knowledge 
between Caucasian and African South Africans.  Down syndrome was previously 
considered by the medical profession to be rare in the African population in sub-Saharan 
Africa, including in South Africa.  This has since been proven erroneous. Christianson et al 
(1995) documented that it was more difficult to recognize Down syndrome in African 
neonates, and Christianson & Kromberg (1996) stated that even after counselling African 
mothers did not recognize the differences in their newborns that had Down syndrome.  In 
the African population, there is no word for Down syndrome and it was not recognized as 
an entity (Christianson 1996). Due to the significant mortality of Down syndrome infants 
between birth and 2 years, individuals with Down syndrome do not form a significant or 
recognisable group in the population due to this early mortality (Christianson 1996).  
Affected individuals in the African population are therefore grouped together with other 
intellectual disabilities and are not distinguished specifically or individually as Down 
syndrome.   
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A contributory reason may also be that as Down syndrome was thought to be rare in 
Africans, doctors did not and still do not refer African women who are of AMA for genetic 
counselling. These women are therefore not being educated about Down syndrome and the 
community remains unaware (Kromberg et al 1992).  The Caucasian population has been 
made more aware of Down syndrome by public education, information from literature and 
because of their access to more comprehensive health care in their medical insurance based 
health care system. 
 
The researcher determined whether the knowledge of women who have children with 
Down syndrome was influenced by education level (figure 3.3.2).  Of the women who had 
no education, none of them knew what Down syndrome was prior to the diagnosis of their 
child; 1 of the 11 women who had less than 7 years of schooling knew what Down 
syndrome was, whereas 6 of the 21 women with 7-12 years schooling, and 10 of the 13 
women with tertiary education knew what Down syndrome was. 
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FIGURE 3.3.2: Did education level influence knowledge of Down syndrome prior to birth 
of child 
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The Pearson Chi-square for the data in figure 1.6 of 16.57 and subsequent p-value of 
0.00087 was significant evidence that education level influenced knowledge regarding 
Down syndrome.   
 
Of the 13 women who had tertiary education, 8 were Caucasian (61.5%). Three of those 
with tertiary education (two African and one Caucasian) did not know what Down 
syndrome was prior to the birth of their child with Down syndrome. 
 
Pelser (1998) also documented that knowledge was dependant on the level of education in 
women of advanced maternal age when questioned about their knowledge of Down 
syndrome.  Of the women with less than 10 years education, 42.42% knew what Down 
syndrome was, whereas 88% and 100% of women with 10-12 years education and over 12 
years education respectively knew Down syndrome. 
 
3.4 INFORMATION ON THE PREGNANCY WITH THE CHILD WITH DOWN SYNDROME 
At the time of the pregnancy with the child with Down syndrome, 21 (42%) of the women 
were of advanced maternal age (AMA).  Of these women, 3 were Caucasian (30% of 
Caucasian group) and 18 were African (50% of African group).  The maternal ages at the 
time of the birth of their child with Down syndrome ranged from 18 years to 45 years 
(Table 3.4.1), with a mean age at the time of pregnancy of 33 years. 
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TABLE 3.4.1: Maternal Age Distribution at Time of Birth of child with Down syndrome 
 
AGE 
(years) 
African  Caucasian Indian TOTAL 
No. 
Percent 
(%) of total  
Under 20   1 1 2 
20-24 2 2  4 8 
25-29 6 1 2 9 18 
30-34 9 4 1 14 28 
35-39 12 2  14 28 
40-44 6 1  7 14 
45-49 1   1 2 
 
 
Statistics South Africa (2004) reported the recorded live births according to the age of the 
mother.  This is shown in comparison to the maternal ages of the mothers of this study in 
Table 3.4.2, as well as in Figure 3.4.1.  These show that there is a greater proportion of 
older mothers who have children with Down syndrome in comparison to the general 
population. 
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TABLE 3.4.2: Maternal age at time of birth of child with DS compared to maternal age 
distribution of general population 
AGE (years) Percent (%) of mothers 
with children with DS 
Percent (%) of mothers 
of general population 
Under 20 2 16 
20-24 8 26 
25-29 18 22 
30-34 28 18 
35-39 28 11 
40-44 14 5 
45-54 2 1 
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FIGURE 3.4.1: The distribution of maternal ages in the mothers who have children with 
Down syndrome compared to the maternal ages in the general population 
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This is in keeping with the three prospective studies in South Africa in which the Down 
syndrome birth prevalence in African newborns was shown to be as high as or higher than 
that occurring in populations in industrialized nations (Christianson 1996).  These studies 
showed that 52-56% of infants with Down syndrome are born to mothers of advanced 
maternal age (Kromberg et al 1992). 
 
The prenatal diagnostic technique performed to diagnose chromosome abnormalities 
specifically Down syndrome in pregnancies of women who are of advanced maternal age is 
usually amniocentesis (Harper 2004). This has been available to a limited extent in the 
public health sector and more accessibly in the private health sector in South Africa since 
the late 1970’s (Kromberg et al 1989). 
 
It has been suggested in studies from developed countries, that one of the reasons women 
did not have amniocentesis performed was due to lack of education (Epstein et al 1972, 
Shino & Kellogg 1977).  Kromberg et al (1992) documented that the majority of African 
women were unaware of the existence of prenatal amniotic services and that only 5% of 
amniocenteses performed in Johannesburg in 1990 were on African women, who comprise 
90% of the pregnant population. Schön (2004) found that only 12% (9 out of 70) of African 
women were aware of prenatal diagnosis.  She also documented that a majority of AMA 
women in her study (70%) were not referred for genetic counselling when their pregnancy 
was initially confirmed while a minority presented too late in their pregnancy to be offered 
genetic counselling and invasive testing.   
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In the present study, none of the women had had prenatal diagnosis during the pregnancy 
that resulted in the birth of a child with Down syndrome.  In question number 21 
(Appendix A) asking about whether or not they would have opted for prenatal diagnosis 
had it been offered to them, 70% of the mothers answered in the affirmative. Of the African 
women 29 (81% of the African population) answered yes, 6 (17% of African population) 
answered no and 1 (2%) answered maybe to this question.  Of the Caucasian women, 5 
(50%) answered yes, 4 (40%) answered no and 1 (10%) answered maybe to the question 
(figure 3.4.2). 
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FIGURE 3.4.2: Would mothers have opted to have prenatal diagnosis had they been 
offered 
 
The Pearson Chi-square statistic for this data was 3.89 (df=2 p=0.14), which indicated that 
the decision making process of all women with respect to their decision to accept or reject 
prenatal diagnosis was independent of ethnicity (p-value > 0.05). 
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For comparison, in a previous study, from a sample of African women in South Africa with 
Down syndrome infants, none of whom had been offered prenatal diagnosis during 
pregnancy, 73% would have asked for amniocentesis if it had been offered (Kromberg et al 
1992).  In another South African study at the Groote Schuur Hospital, Cape Town, 316 
women, from mixed ancestry, and black and white population groups, were offered 
amniocentesis, and 75.9% accepted to have the procedure (Viljoen, Oosthuizen & van der 
Westhuizen 1996).  Pelser (1998) also documented that 89.13% (41) of African women and 
93.3% (28) of Caucasian women in the study opted to have amniocentesis performed based 
on their risks related to advanced maternal age. 
 
3.4.1 Information on child with Down syndrome 
All the children with Down syndrome were still alive at the time of the interview, with their 
ages ranging from 1 year to 32 years of age, with a mean age of 4.6 years.  Most of the 
mothers that were interviewed were attending or had attended clinics because of their child 
with Down syndrome.  Death amongst children with Down syndrome is common 
(discussed in section 1.1.4) but only mothers with live children with Down syndrome were 
interviewed. It is a limitation of the study and possibly a more comprehensive conclusion 
could be made on the topic if the opinion of mothers who had children with Down 
syndrome that had died was obtained.  However, getting access to these mothers would be 
difficult and it would be traumatic for the mothers to be interviewed on the subject.  
 
The ages of the African children with Down syndrome ranged from 1 to 10 years with a 
mean age of 3.2 years.  The Caucasian children with Down syndrome were between 2 and 
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32 years of age and the mean age was 10.5 years.  In the Caucasian population, when 
excluding the two older individuals of 22 and 32 years, the mean age drops to 5.8 years.  
This indicates that in both populations, the children were of an age that ensured most of the 
mothers had to have confronted reproductive issues and made decisions. 
 
3.5 REPRODUCTIVE CHOICES OF WOMEN AFTER HAVING A CHILD WITH DOWN SYNDROME 
After the birth of their child with Down syndrome, the majority of the women did not have 
further children. However, there was a significant difference between the African and 
Caucasian groups.  Almost all (35 out of 36 or 97%) of the African women had not had 
children after their child with Down syndrome was born, whereas 5 (50%) of the Caucasian 
women did have more children (figure 3.5.1). The Pearson Chi-square statistic for this data 
was 15.88 (df=2 p=0.00036), which indicates that there is a significant difference between 
the two groups.   
 
This may be explained by the fact that more of the African women were of advanced 
maternal age and were possibly not going to have more children regardless of whether the 
child had Down syndrome or not.  It may also be explained by the fact that more of the 
Caucasian women were aware of the risks for their next pregnancies (in most cases, the 
recurrence risk was considered to be low, i.e. 1%) as well as the options available for them 
with regards to prenatal testing (see figure 1.10).  Mgone (1982) noted in a study of African 
mothers with children with Down syndrome that their reproductive attitudes and behaviour 
were unchanged after the birth of their child with Down syndrome.  The mothers who did 
not want to have further children gave the reason that it was due to their advanced maternal 
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age rather than their Down syndrome infant.  Christianson (1996) noted that the mothers 
may have given this reason due to the lack of awareness of the aetiology, features and 
prognosis of Down syndrome.  That African women in the study did not have further 
children may indicate that with counselling and information, they decided against having 
future children. 
 
The birth order of when the child with Down syndrome was born in comparison to siblings 
was determined.  In the African population, 26 of the 36 children (72%) were third or 
higher in the birth order, but only 1 (10%) in the Caucasian population was third in the 
birth order. In the African population, 11 (30.6%) were fourth or higher in the birth order.   
The average was 1.6 in the Caucasian population whereas in the African population, the 
average was 3.14, and 3 in the Asian population. Christianson et al (1996) reported that 
60% of children with Down syndrome, born to African mothers in South Africa, were 
fourth or higher in the birth order and Adeyokunnu (1982) noted this in 76% of his cases. 
 
Only 7 (14%) of the women (5 Caucasian women, 1 African woman and 1 Asian woman) 
had subsequent children after their child with Down syndrome was born. Subsequent to 
their child with Down syndrome, five of these women had one child and two had two 
children each 
 52 
0
5
10
15
20
25
30
35
40
0 1 2
No. of children subsequent to DS child
No
.
 
o
f m
o
th
e
rs
African 
Asian
Caucasian
 
FIGURE 3.5.1: Number of children that mothers had subsequent to their child with Down 
syndrome 
3.6 GENETIC COUNSELLING 
Once the child had been diagnosed with Down syndrome, 38 (76%) of the mothers 
received some form of counselling from a nurse, doctor or genetic counsellor, and 12 
(24%) did not (figure 3.6.1).  It was not possible however, to ascertain as to how 
comprehensive it was, or to establish the specific details of the counselling. 
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FIGURE 3.6.1:  Did mothers receive genetic counselling 
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Comparing the ethnic groups, the majority, 90% (9) of the Caucasian women received 
counselling, compared to 72% (26) of the African women and 75% (3) of the Asian women 
(figure 3.6.2).   
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FIGURE 3.6.2: Distribution of mothers who received counselling among ethnic groups  
 
These results differ from the cohort of African mothers seen by Mgone (1982).  He found 
in the mothers in his study whose reproductive behaviour had remained unchanged after the 
birth of their child with Down syndrome that none of them had received any counselling 
for Down syndrome, whereas 76% of the mothers interviewed in this study received 
counselling and few (16%) had further children. 
 
If the sample group of mothers had received counselling, they were asked by whom they 
had been counselled.  Most of the mothers, 22 (44%), were counselled by a doctor.  Five of 
these mothers were unsure which type of doctor specifically, whereas 12 said they were 
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counselled by a paediatrician, 3 by a gynaecologist and 1 by a geneticist.  Ten mothers 
(20%) received counselling from a Genetic counsellor, 2 (4%) from a nurse, 3 (6%) from 
the Down Syndrome Association, and 1 (2%) from a social worker. 
 
Of these women (n=38) who were counselled, 28 (73%) were told their risks in future 
pregnancies and 10 (26%) reported that they were not told risks.  Of the African women 
with a child with Down syndrome, 21 (58%) said that they were told their risks in future 
pregnancies and 7 (70%) Caucasian women reported that they were told their risks.  
Counselling seemed to be variable.  Only 12 (31.6% of the women counselled) women 
remembered their specific risk. One African woman said she was told her risk to have 
another baby with Down syndrome was 100% despite having two other children who do 
not have Down syndrome. Three Caucasian women said they were told that their risk was 
50%, 4% and 25% respectively.  The rest of the women said that they were told their risks 
were 1% or less.  The researcher feels that these women may not have been correctly 
counselled, as some of the risks seem very high, or considers that some of the women did 
not recall the information accurately.  
 
With regards to future pregnancies, 29 (58%) of the mothers were advised about the option 
of prenatal diagnosis and 17 (34%) of the mothers were not.  The option was not applicable 
to 4 (8%) of the women as they were not going to have more children, as 3 had undergone 
tubal ligation and 1 woman stated that she was not sexually active. 
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3.7 FAMILY PLANNING 
When the mothers were asked whether they were using any contraception after the birth of 
their child with Down syndrome, 12 (24%) said they had not used or were not using 
contraception, although the majority, 38 (76%) of the mothers had used and were still using 
contraception.  These figures include the women who had tubal ligation and the one who 
said she was not sexually active. 
 
The contraceptive prevalence in South Africa was found to be 56% (UNICEF 2004). 
This is substantially less than the 76% of women who have children with Down syndrome 
using contraceptives, which possibly indicates that the majority of women did not want to 
have further children after a child with Down syndrome, and implies that their reproductive 
behaviour changed subsequently.  This change occurred subsequently to the genetic 
counselling received by these mothers. 
 
3.8 INFORMATION ON PREGNANCIES SUBSEQUENT TO THE BIRTH OF THE CHILD WITH 
DOWN SYNDROME 
Amongst the 7 (14%) mothers who did have children subsequently to their Down syndrome 
child, there were 8 pregnancies altogether.  Of these pregnancies, 6 (75%) were planned 
and two (25%) were unplanned.  Five of these women said that the pregnancies were 
planned; one said that it was unplanned and one woman said that one of her pregnancies 
was planned and one was unplanned.  Of these women, 5 were Caucasian, one was Indian 
and one was African.  Table 3.8.1 summarises the prenatal testing during the subsequent 
pregnancies. 
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TABLE 3.8.1: Prenatal testing in pregnancies subsequent to DS child 
 
      KEY: Y= Yes; N= No 
 
Six of the 7 mothers had counselling after their child with Down syndrome was born.  With 
regard to the 8 subsequent pregnancies, 7 ultrasound examinations were performed and one 
woman, although she did not have ultrasound, had an amniocentesis in the 1970’s.  All 
mothers thus had some form of prenatal screening or diagnosis.  In the 7 pregnancies where 
women had ultrasound, at least one other prenatal test was performed: 4 nuchal 
translucencies (see glossary), 5 triple tests (see glossary), and 5 amniocenteses were 
performed.  The results of prenatal testing were all normal and all the women continued 
with their pregnancies.   
 SCREENING TESTS DIAGNOSTIC TESTS 
MOTHER RECEIVED 
COUNSELLING  
PLANNED 
PREGNANCY 
ULTRASOUND NT TRIPLE 
TEST 
AMNIOCENTESIS CVS 
1 Y One:  Y 
Two:  N 
Y 
Y 
N 
N 
Y 
Y 
Y 
Y 
N 
N 
2 Y Y Y Y Y N N 
3 Y N Y Y Y Y N 
4 N Y Y Y N N N 
5 Y Y Y Y Y N N 
6 Y Y N N N Y N 
7 Y Y Y N N Y N 
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All 7 women wanted to have some form of prenatal testing in their pregnancies after their 
child with Down syndrome was born and in 5 of the 8 pregnancies (62.5%) they opted for 
invasive testing.  Of the 3 women who did not have amniocentesis, all had other prenatal 
testing and 2 received genetic counselling, suggesting that they had made an informed 
decision not to have amniocentesis performed. 
 
This is a further indication that the counselling that the women interviewed had received 
after the birth of their child with Down syndrome had impacted on their future reproductive 
behaviour. 
  
3.9 WOULD WOMEN WANT PRENATAL DIAGNOSIS IN FUTURE PREGNANCIES 
The women were asked whether they would want to have prenatal diagnosis (PD) in future 
pregnancies.  Of all the women interviewed, 38 (76%) said that they would have prenatal 
diagnosis in any future pregnancies, 7 (14%) said they would not, and 5 (10%) said they 
were unsure whether they would have prenatal diagnosis (figure 3.9.1). 
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FIGURE 3.9.1: Would mothers want prenatal diagnosis in future pregnancies 
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These data confirm that the majority of women would opt to have prenatal diagnosis.  Of 
the Caucasian women, 80% (8) would want prenatal diagnosis in future pregnancies and 
20% (2) would not.  Similarly, 80.6% (29) of the African women would want prenatal 
diagnosis, 8.3% (3) would not and 12.1% (4) were unsure. Of the Asian women, 25% (1) 
answered yes, 50% (2) answered no and 25% (1) were unsure when questioned whether 
they would want prenatal diagnosis in future pregnancies. 
  
Prenatal diagnostic techniques, such as amniocentesis and ultrasonography, are available to 
women in the private health care sector and at selected academic and state hospitals for the 
women who cannot afford private fees.  Pelser (1998) interviewed women who were of 
AMA and found that 90% of Caucasian women, but only 52% of African women, were 
aware that prenatal diagnostic tests were available to them.  She proposed that the lack of 
awareness and underutilization of services in South Africa could be due to: 
• Lack of availability of prenatal tests 
• Limited knowledge regarding prenatal diagnostic services 
• Medical personnel failing to inform women regarding the tests 
• DS and the risk of AMA previously being unrecognized by African women 
(Christianson 1996)  
 
This highlights the need to increase awareness of prenatal diagnostic services, as well as 
referrals from practitioners, as many women would opt for testing.  Pelser (1998) reported 
that in Pretoria a large number of women who obtained prenatal care at peripheral clinics 
were not counselled about advanced maternal age and their risks and thus missed the 
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opportunity for genetic counselling and prenatal diagnosis.  Many women also presented 
too late in pregnancy to be offered amniocentesis. Public education regarding advanced 
maternal age, the associated risks and the availability of genetic counselling is therefore 
essential. Many of the women who do book in early are not referred. Schön (2004), in a 
study, “Missed opportunities for prenatal diagnosis in women of AMA”, found that 70% of 
these women presented for pregnancy confirmation early enough to be offered genetic 
counselling and prenatal testing.  The average gestational age, at which the pregnancy of 
these women was confirmed, was 12.8 weeks gestation, yet none were appropriately 
referred for genetic counselling or given the option of prenatal diagnosis.  Medical and 
nursing staff in primary, secondary and tertiary hospitals should be aware of the availability 
of amniocentesis so as to increase the number of women referred early in pregnancy for 
genetic counselling and to be given the option of amniocentesis.  The public and medical 
personnel therefore should be informed about the risks of AMA and the availability of 
prenatal diagnosis, made aware of women at risk and as to which women should be 
referred for these tests. 
 
3.10 WOULD WOMAN CONSIDER TOP IF FETUS FOUND TO HAVE DOWN SYNDROME 
Of the 50 women interviewed, 21 (42%) said they would terminate a pregnancy (TOP) if 
Down syndrome were to be detected in a future pregnancy, 26 (52%) said they would not, 
and 3 (6%) said they were unsure what they would do if faced with this problem (figure 
3.10.1). 
 
Deleted: Pelser (1998) also 
noted that if amniocentesis was 
offered to all women over the age 
of 40 years, 28% of DS fetuses 
could potentially be diagnosed and 
that if amniocentesis was offered 
to all women over the age of 35 
years, 52% of all DS fetuses could 
possibly be detected. 
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FIGURE 3.10.1: Mothers who would consider TOP in a subsequent pregnancy if fetus 
found to have Down syndrome 
 
Of the Caucasian women, 40% (4) said they would opt for TOP, 40% (4) said they would 
not and 20% (2) were unsure. Of the African women, 52.7% (19) said they would not 
terminate an affected fetus, 44.4% (16) said that they would and one (2.8%) woman was 
unsure.  Of the Asian women, 75% (3) said that they would not terminate an affected fetus 
and one (25%) said she would.   
 
In a previous study, from a sample of African women in South Africa with Down 
syndrome infants, 52% would have terminated the pregnancy if prenatal diagnosis had been 
offered to them and showed an abnormal result (Kromberg et al 1992).   
 
In a survey by Elkins et al (1986), mothers of children with Down syndrome in an 
American population were questioned concerning their attitudes with respect to prenatal 
diagnosis and TOP.  The sample consisted of 101 women of whom 40 had children 
subsequently to their child with Down syndrome. Of these women, 50% had amniocentesis 
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in subsequent pregnancies and only half of these women (25%) said they would terminate 
the pregnancy if Down syndrome were confirmed.   
 
Figure 3.10.2 represents the comparison between the Caucasian and African women. 
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FIGURE 3.10.2: Comparison of Caucasian and African mothers’ choice with regards to 
TOP of a fetus with Down syndrome 
 
The Pearson Chi-square statistic for these data was 3.85 (df=2 p=0.15), which indicated 
that the decision making process of all women was independent of ethnicity (p-value > 
0.05).  These results compare favourably with other studies;  Pelser (1998) concluded that 
acceptance of TOP, after non-directive counselling for a birth defect, was not influenced by 
ethnicity and Viljoen et al (1996) documented that ethnicity, education and socio-economic 
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class did not influence woman’s acceptance of prenatal diagnosis, but that religion 
influenced decisions regarding amniocentesis and TOP. 
 
It is interesting to note that a recent study on South African women revealed that 80% of 
Caucasian women would consider TOP for a severe anomaly compared to 63% of African 
women.  The overall acceptance rate of TOP for a birth defect anomaly was 69.7% (Pelser 
1998). Similarly, Viljoen et al (1996) documented that of 466 women, from African, 
Caucasian and mixed ancestry, the overall TOP acceptance rate was 76.3%. Although these 
figures are much higher than the figures for women who have had a child with Down 
syndrome, all severe congenital abnormalities are included, and the study did not 
necessarily include women who previously had a child with Down syndrome.  
 
In a study on women with Down syndrome children of primary school age, results 
indicated that negative feelings that they had felt initially at the birth of the child with 
Down syndrome had almost invariably changed in a positive direction and the experience 
of depression or anxiety among these mothers was uncommon.  The families were 
described as enmeshed and controlled, and the experience of the family situation was 
generally positive (Ryde-Brandt 1988).   This may explain why only a limited number of 
mothers in the present study would consider TOP of a fetus with Down syndrome in a 
future pregnancy. 
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3.11 LIMITATIONS OF THE STUDY 
The researcher recognized the following limitations of the study: 
• The sample in this study does not necessarily represent the attitudes of all women 
with children with Down syndrome in the South African population as only mothers 
who currently live in Johannesburg, Gauteng were interviewed. 
• The ages of the children with Down syndrome in this study ranged from 1 to 32 
years and may present a limitation in that mothers who have very young children 
may not have experienced the same long-term complications as mothers of older 
children with Down syndrome. 
• Responses from mothers whose first language differed from that of the interviewer 
may not have been accurately interpreted either by the interpreter or by the 
interviewer. 
• Women may not have been completely comfortable to discuss sensitive issues such 
as their attitudes towards prenatal testing and TOP. This may have biased the 
results. 
 
3.12 RECOMMENDATIONS 
The following recommendations can be made from the findings of this study: 
o Further research in other areas of Gauteng and in other provinces of South Africa 
could provide more in-depth insight into the reproductive choices of women with 
children with Down syndrome. 
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o Doctors, nursing staff and the lay public should be made aware  with respect to 
risks associated with advanced maternal age, genetic counselling services and the 
reproductive options available to women. 
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CHAPTER 4 
CONCLUSION 
 
This study documented the reproductive choices made by South African mothers who have 
children with Down syndrome (DS).  The reproductive decisions with respect to future 
family planning, prenatal diagnosis and termination of pregnancy, were assessed by using a 
questionnaire administered by the researcher to the women. The analysis of the 
questionnaire was performed with respect to ethnicity, education level and socio-economic 
status. 
 
The information gained from the interviews showed that only one third of mothers knew 
about Down syndrome before their child with DS was born. Of these mothers, most had 
only a very basic knowledge and did not understand the severity and prognosis of the 
disorder. However most of the women received early counselling upon the diagnosis of 
Down syndrome in their child and those who did not, received counselling subsequently as 
they were attending DS clinics.  After counselling, almost all of the African women 
stopped having further children while half of the Caucasian women had further children.  
Of the women who did have further children, all of them had some form of prenatal testing.   
 
These results correlate significantly to those of other studies confirming that:  
1) African women do not know about Down syndrome or are aware of the risks to 
women of advanced maternal age of having a baby with Down syndrome (Pelser 
1998; Schön 2004). 
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2) Most African women of advanced maternal age are not being offered genetic 
counselling and prenatal diagnosis (Kromberg et al 1992; Pelser 1998; Schön 
2004). 
 
However, after the birth of a child with Down syndrome, many South African women in 
this study received some counselling that seemed to impact on their subsequent 
reproductive behaviour.  After the birth of their child with DS the majority of women in 
this study used contraception, and only few have had subsequent children.  This is in 
contrast to Mgone’s (1982) findings that the reproductive behaviour of Tanzanian women 
remained unchanged after the birth of a child with Down syndrome.  These women had 
however not received counselling.  The women who did have children subsequent to the 
birth of their child with Down syndrome all had some form of prenatal screening or 
diagnosis.  The behaviour of women in this study is more similar to that of women in 
industrialised countries, such as Japan and America (Ando 1978; Elkins et al 1986). 
 
This study showed that in Johannesburg postnatal counselling to women who had a child 
with Down syndrome appears to have changed their subsequent reproductive behaviour.  
Genetic counselling for DS aims to inform individuals and families of the nature of Down 
syndrome, the probability of having children with Down syndrome in future pregnancies 
and the options available in which this can be detected prenatally and prevented (Harper 
2004).  The results documented in this study indicate that the majority of South African 
mothers of children with DS living in Gauteng are receiving counselling that impacts their 
Deleted: ed
Deleted: South Africa
Deleted: have 
Deleted: syndrome 
Deleted: is effective as women 
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future reproductive behaviour.  This confirms the need for parents of infants and children 
with Down syndrome to be referred and given genetic counselling. 
 
The researcher considered it important to document this information to assist in the 
understanding of mothers and families that receive genetic counselling for Down syndrome 
and thus enhance and give increased insight to the Genetic Counselling services offered by 
the Department of Human Genetics, University of the Witwatersrand & the National Health 
Laboratory Service in South Africa. 
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APPENDIX A 
 
 
QUESTIONNAIRE                                                  
        Research No:____________ 
 
 
General Information: 
 
1. Age:____________________________________ 
 
2. Home Language:_______________________________ 
 
3. How many years of school did you complete? 
 
 None 
 1-7 
 7-12 
 Tertiary 
 
4. Which province do you live in?__________________ 
 
5. What area do you live in? 
 
 Urban 
 Peri-urban 
 Rural 
 
6. Occupation:__________________________________ 
 
7. Husband’s occupation:_________________________ 
 
8. What is your household salary? 
 
 0 - R1000 
 R1000 - R5000 
 R5000 - R10 000 
 R10 000 - R20 000 
 Over R20 000 
 
Previous Pregnancy History: 
 
9. Para (how many deliveries you have had):________________________ 
 
10. Gravida (how many pregnancies you have had):___________________ 
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11. How many live children do you have?____________________________ 
 
12. Age of child with Down Syndrome:______________________ 
 
13. Is this child still alive? 
 
 Yes 
 No 
 
14. Did you know about Down syndrome before the birth of the affected child? 
 
 Yes 
 No 
 
15. If yes, what did you know?_____________________________________ 
 
16. How many children have you had subsequent to your child with Down 
Syndrome?__________________ 
 
17. Did you have prenatal diagnosis during the pregnancy with your child with Down 
syndrome? 
 
 Yes 
 No 
 
18. If yes, why? 
 
 Because of an increased risk due to AMA  
 Because of an increased risk from prenatal screening 
 Because of an increased risk due to previous child with Down syndrome 
 
19. Were there any abnormal findings after prenatal diagnosis? 
 
 Yes 
 No 
 
20. If yes, what were the findings?_________________________________________ 
 
21. If you did not have prenatal diagnosis, would you have chosen to have prenatal 
diagnosis if you knew you had an increased risk for Down syndrome? 
 
 Yes 
 No 
 Maybe 
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22. After the diagnosis of your child with Down syndrome, did you receive counselling? 
 
 Yes 
 No 
 
23. If yes, who counselled you about your child with Down syndrome? 
 
 Nurse  
 Doctor  
a) Paediatrician 
b) Gynaecologist 
c) General Practitioner 
d) Geneticist 
 Genetic Counsellor 
 
24. During counselling for another child with Down Syndrome, were you told about your 
risks in future pregnancies?  
 
 Yes 
 No 
 
25. If yes, what were the risks you were given? 
 
 Increased 
 Decreased 
 Specific figure:______________________ 
 
26. Were you advised about the option of prenatal diagnosis in future pregnancies? 
 
 Yes 
 No 
 
27. Did you use contraception after the birth of your child with Down syndrome? 
 
 Yes 
 No 
 
28. Were your pregnancies after your child with Down syndrome planned? 
 
 Yes 
 No 
 
29. If yes, what were you advised?________________________ 
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30. Did you have prenatal diagnosis in any of the pregnancies after the birth of your child 
with Down syndrome?  
 
 Yes 
 No 
 
31. If yes, what prenatal diagnosis? 
 
 Ultrasound 
 Nuchal Translucency 
 Triple Test 
 Amniocentesis 
 CVS 
 
32. What were the results of the prenatal diagnosis?___________________________ 
 
33. If an abnormality was found, what was the diagnosis?______________________ 
 
34. Did you: 
 
 Continue with the pregnancy    
 Have a TOP 
 I miscarried  
 
35.  In any future pregnancies, would you want to have prenatal diagnosis? 
 
 Yes 
 No 
 Not sure 
 
 
36. In subsequent pregnancies, would you consider (or would you have considered) 
termination of pregnancy if it was discovered that the fetus had Down syndrome? 
 
 Yes 
 No 
 Not sure 
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APPENDIX B 
 
 
PATIENT INFORMATION SHEET 
 
Research Title:  THE REPRODUCTIVE CHOICES MADE BY SOUTH AFRICAN MOTHERS   WHO 
HAVE CHILDREN WITH DOWN SYNDROME 
 
Researcher:     Julie Lampret 
  MSc(Med) Genetic Counselling, 2nd year 
  Department of Human Genetics, University of the Witwatersrand 
 
Supervisor:     Professor AL Christianson, FRCP Ed 
Department of Human Genetics, NHLS 
University of the Witwatersrand   (011) 489-9223  
 
I am an MSc(Med) student at the Department of Human Genetics of the National Health 
Laboratory Service, School of Pathology, University of the Witwatersrand. I am conducting a 
study to determine what reproductive decisions are made by South African women, who have 
previously had a child with Down syndrome. 
 
As a mother of a child with Down syndrome, we would appreciate your help and participation 
in this study.  This would assist us in determining what reproductive decisions (choices made 
during pregnancy) are made by women like yourself with regard to family planning (e.g. 
contraception) and prenatal diagnosis (diagnosis of the baby during pregnancy).  You will 
therefore be asked questions relating to the choices you made in any pregnancies before or 
after your child with Down syndrome was born. This will help us improve our understanding 
of the psychological (emotional) and social factors surrounding Down syndrome. 
 
If you agree to help with the study, you will be asked to answer a number of questions in an 
interview by myself, which should not take more than an hour of your time.  The information 
you give will remain strictly confidential and your name will not appear on the questionnaire.  
 82 
The results of this study will be analysed anonymously and will be used to help us better 
understand how women and their families cope with children with Down syndrome.  This may 
give us further insight into managing our services effectively. 
 
If you choose not to participate, this will not affect the management or treatment of you or 
your child in any way.  Your participation in this study is entirely voluntary and you are free 
to withdraw at any time. 
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APPENDIX C 
 
 
INFORMED CONSENT 
 
I,.................................................................. consent to participate in a study which involves the 
completion of a questionnaire regarding my experiences as a mother of a child with Down 
Syndrome.  I understand that the information will remain confidential, and is for research 
purposes.  I understand that I may withdraw from this study without any negative impact on 
myself or my child. 
 
Signature:..................................................... 
 
Date:............................................................. 
 
Phone Number:............................................. 
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APPENDIX D 
 
 
ETHICAL CLEARANCE CERTIFICATE 
 
